The U.S. Preventive Services Task Force last month provided two windows into its analytical approach to evaluating the benefits and risks of preventative services and diagnostic.

In one case, USPSTF used conflicting and limited data to condemn PSA screening for prostate cancer (see "Lessons from PSA Debate," A8).